The impaired Breg activity may contribute to the development of MS and EAE, as mice deficient in Breg-derived IL-10 and IL-35 develop exacerbated EAE with failed recovery, while elevated IL-35+ or IL-10+ Bregs ameliorate disease severity (55, 56). This evidence concerns the gene IL10 and myeloid sarcoma.